BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Rapamycin effect on Wild Type and TSC deficient Mouse Embryonic Fibroblasts : Time Course

Dataset: Rapamycin effect on Wild Type and TSC deficient Mouse Embryonic Fibroblasts : Time Course

Aberrant activation of the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) is a common molecular event in a large variety of...

Registered by ArrayExpress Uploader
View Dataset

Aberrant activation of the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) is a common molecular event in a large variety of pathological settings, including genetic tumor syndromes, cancer, and obesity. However, the cell intrinsic consequences of mTORC1 activation remain poorly defined. Here, we identify global trancriptional changes in TSC1 and TSC2 null MEFs, which exhibit constitutive activation of mTORC1, compared to wild-type littermate control lines. A rapamycin time course is included to determine those changes that are dependent on mTORC1 signaling, revealing mTORC1 induced and repressed transcripts. In order to identify mTORC1-dependent transcriptional changes, we compared wild-type MEFs to both Tsc1-/- and Tsc2-/- MEFs following serum starvation, where mTORC1 signaling is off in wild-type cells and fully active in TSC-deficient cells. All cell lines were serum-starved for 24 h, and the Tsc1-/- and Tsc2-/- cells were treated with a time course of rapamycin prior to the isolation of mRNA for microarray analysis. Immortalized wild-type (Tsc2+/+ p53-/-), Tsc1-/- (p53+/+, 3T3-immortalized), and Tsc2-/- (p53-/-, derived from a littermate of the wild-type cell line) MEFs are the three cell lines used in this study and were derived in the laboratory of David J. Kwiatkowski (Brigham and Women's Hospital, Harvard Medical School, Boston, MA). Wild-type and null MEFs were grown to 70% confluence in 10 cm plates and were serum starved for 24 h in the presence of vehicle (DMSO) for 24 h or rapamycin (20 nM) for 2, 6, 12, or 24 h. All vehicle-treated samples (0 h time points) were plated in triplicate and all rapamycin time course samples were plated in duplicate. For each replicate, expression analysis was performed by hybridization to an Affymetrix Mouse 430_2 oligonucleotide microarray chip.

Species:
mouse

Samples:
25

Source:
E-GEOD-21755

PubMed:
20670887

Updated:
Dec.12, 2014

Registered:
Nov.11, 2014


Factors: (via ArrayExpress)
Sample CELL LINE TIME POINT GENOTYPE/VARIATION AGENT
GSM542346 TSC2+/+ p53-/- not specified Wild Type DMSO
GSM542346 TSC2+/+ p53-/- not specified Wild Type DMSO
GSM542346 TSC2+/+ p53-/- not specified Wild Type DMSO
GSM542349 TSC2-/- p53-/- not specified TSC2 Deficient DMSO
GSM542349 TSC2-/- p53-/- not specified TSC2 Deficient DMSO
GSM542349 TSC2-/- p53-/- not specified TSC2 Deficient DMSO
GSM542352 TSC1-/- not specified TSC1 Deficient DMSO
GSM542352 TSC1-/- not specified TSC1 Deficient DMSO
GSM542352 TSC1-/- not specified TSC1 Deficient DMSO
GSM542355 TSC2-/- p53-/- 24 hours TSC2 Deficient rapamycin
GSM542355 TSC2-/- p53-/- 24 hours TSC2 Deficient rapamycin
GSM542357 TSC1-/- 24 hours TSC1 Deficient rapamycin
GSM542357 TSC1-/- 24 hours TSC1 Deficient rapamycin
GSM542359 TSC2-/- p53-/- 12 hours TSC2 Deficient rapamycin
GSM542359 TSC2-/- p53-/- 12 hours TSC2 Deficient rapamycin
GSM54236 TCS1-/- 12 hours TSC1 Deficient rapamycin
GSM542362 TSC1-/- 12 hours TSC1 Deficient rapamycin
GSM542363 TSC2-/- p53-/- 6 hours TSC2 Deficient rapamycin
GSM542363 TSC2-/- p53-/- 6 hours TSC2 Deficient rapamycin
GSM542365 TSC1-/- 6 hours TSC1 Deficient rapamycin
GSM542365 TSC1-/- 6 hours TSC1 Deficient rapamycin
GSM542367 TSC2-/- p53-/- 2 hours TSC2 Deficient rapamycin
GSM542367 TSC2-/- p53-/- 2 hours TSC2 Deficient rapamycin
GSM542369 TSC1-/- 2 hours TSC1 Deficient rapamycin
GSM542369 TSC1-/- 2 hours TSC1 Deficient rapamycin

Tags

  • cancer
  • cell
  • line
  • obesity
  • serum

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use